Viewing Study NCT06490978



Ignite Creation Date: 2024-07-17 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06490978
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-08
First Post: 2024-02-27

Brief Title: Predictors of Early Hematoma Expansion in Patients With Acute Intracerebral Hemorrhage Clinical and Laboratory Study
Sponsor: Assiut University
Organization: Assiut University

Study Overview

Official Title: Predictors of Early Hematoma Expansion in Patients With Acute Intracerebral Hemorrhage Clinical and Laboratory Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aim to develop inflammatory score based on proper integration of several inflammatory markers and investigate whether it was associated with hematoma expansion and poor outcomes in patients with ICH
Detailed Description: Intracerebral hemorrhageICH accounts for approximately a quarter of all stroke subtypes with high mortality and the survi- vors always have varying degrees of residual disability However few medical and surgical treatments are clearly beneficial comparing with ischemic stroke Hematoma expansion which is a determinant of poor outcomes occurs in about 30 of ICH patients especially at the early stage Attenuating hema- toma expansion is a compelling target for ICH treatment while the outcomes have not been accordingly improved after curbing the growth of hematoma in several clinical trials It will be more helpful if a predictor can identify the risk of hematoma expansion and poor outcome rapidly and accurately Thus the antiexpansion treatment to the patients with positive of such predictor is likely to provide clinical benefits

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None